amitriptyline has been researched along with Macular Degeneration in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thus, we quantified the risk of maculopathy with PPS with a focus on risk with duration of use." | 1.72 | Risk of maculopathy with pentosan polysulfate sodium use. ( Bae, SS; Etminan, M; Kezouh, A; Maberley, D; Sodhi, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SS | 1 |
| Sodhi, M | 1 |
| Maberley, D | 1 |
| Kezouh, A | 1 |
| Etminan, M | 1 |
1 other study available for amitriptyline and Macular Degeneration
| Article | Year |
|---|---|
Risk of maculopathy with pentosan polysulfate sodium use.
Topics: Amitriptyline; Cystitis, Interstitial; Humans; Macular Degeneration; Pentosan Sulfuric Polyester; Re | 2022 |